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Oncogene-induced senescence (OIS) is a complex process, in which activation of oncogenic signals 
during early tumorigenesis results in a high degree of DNA replication stress. The ensuing response to 
the DNA damage produces a permanent G1 arrest that prevents unlimited cell proliferation and lessens 
the development of tumours. However, despite the role of OIS in the proliferative arrest resulting 
from an activating oncogenic-lesion has obtained wide support, there is also evidence indicating that 
cells may overcome oncogene-induced senescence under some circumstances. In this study, we have 
investigated the possibility that some of the assumptions on the role of DNA damage response (DDR) 
in triggering OIS may depend on the fact that most of the available data were obtained in mouse 
embryo fibroblast. By comparing the degree of OIS observed in mouse embryo fibroblasts (MEF) and 
mouse embryo astrocytes (MEA) obtained from the same individuals we have demonstrated that, 
despite truthful activation of DDR in both cell types, significant levels of OIS were only detected in 
MEF. Therefore, this uncoupling between OIS and DDR observed in astrocytes supports the intriguingly 
possibility that OIS is not a widespread response mechanism to DDR.
Cellular senescence is a permanent G1 arrest of cell proliferation that limits the lifespan of mammalian cells and 
prevents unlimited cell proliferation. Cellular senescence may be triggered by numerous cell intrinsic and extrin-
sic mechanisms such as the progressive telomere attrition produced by cell replication (replicative senescence), 
or the response to multiple adverse stimuli such as oxidative stress or DNA damage induced by oncogenic stimuli 
(oncogene-induced senescence, OIS). While replicative senescence is largely linked with the aging process or the 
pathogenesis of some degenerative diseases, OIS should be considered as a potent defensive mechanism against 
cancer, since once senescence is activated cells are not capable of developing into tumours1,2.
Although OIS is a complex process in which multiple signalling proteins network to trigger the response, 
accumulating evidence suggests that all of them operate via RB and p531. Activation of oncogenic signals during 
early tumorigenesis leads to an unregulated stimulation of growth promoting genes which results in a high degree 
of DNA replication stress that produces numerous double-stranded DNA breaks. The ensuing DNA damage 
response (DDR) drives the activation of several tumour suppressor networks, including the p16INK4A/RB and 
p19ARF/p53/p21 pathways3,4 which, in turn, trigger OIS, thereby arresting cells within a few cell-division cycles 
after oncogene expression5.
However, despite a plethora of reports on the role of OIS on the proliferative arrest resulting from an activating 
oncogenic-lesion5,6, there is also evidence indicating that cells may overcome OIS under some circumstances7–11. 
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Although the reasons for this different response are still under debate, several factors such as effect of signal 
intensity or the cell type investigated have been proposed. Since most of the studies supporting the dogma that 
OIS is a necessary consequence of DDR have been performed in mouse embryo fibroblasts (MEF), in this report 
we have investigated the differential senescence response in MEF as compared with mouse embryo astrocytes 
(MEA) obtained from the same individuals. Our results indicate that despite a similar degree of DNA damage, 
OIS response is clearly different between MEF and MEA, thus suggesting that some of the assumptions on the 
mechanisms of OIS and its biological implication should be revised.
Results
Wild type (control) primary MEA showed a flat, polygonal shape, with few projections and non-retractile cyto-
plasm. Immunostaining revealed that more than 95% of the cells were positive for GFAP, while no vimentin 
staining was detected, thus ruling out the presence of mesenchymal cells in the culture. In contrast, no GFAP 
staining was detected in MEF (Fig. 1).
Control MEA displayed a clearly lower growth rate when compared with MEF: a two-fold increase in the rela-
tive cell number was observed in MEA after 6 days in culture, while MEF experimented a 4-fold increase in only 4 
days (Fig. 2a and b). Similarly, while lack of RB increased the growth rate in both MEA and MEF, this increase was 
more evident in the latter (Fig. 2a and b). Interestingly, despite this increased proliferative rate, no morphological 
differences were found between Rb+/+ and Rb−/− cells in either MEA or MEF (Fig. 2c and d).
On the other side, ectopic expression of oncogenic Ras resulted in opposite effects in MEA and MEF growth. 
In keeping with previous reports12,13, expression of oncogenic Ras reduced the growth rate in both Rb+/+ and 
Rb−/− MEF, an effect that may be consequence of premature OIS. At odds with this, a dramatic increase in the 
growth rate was observed when HRasV12 was expressed in MEA and, intriguingly, the highest growth rate was 
observed when oncogenic Ras was expressed in MEA lacking RB. Furthermore, along with these differences in 
the growth rate, prominent differences in the morphological characteristics were also detected between MEA 
and MEF. While no appreciable morphological changes were observed in MEF overexpressing HRasV12 (Fig. 2d), 
HRasV12-expressing MEA showed dramatic morphological changes and, although some flat polygonal cells were 
still present, most of MEA displayed very large cytoplasm with long thin projections (Fig. 2c). Although these 
phenotypic changes were observed in both Rb+/+ and Rb−/− MEA, there were much more obvious in the lat-
ter. The intense morphological changes suggest the existence of a transformed phenotype, in fact foci growth 
was induced by HRasV12 expression in either Rb+/+ and Rb−/− postnatal astrocytes. Indeed, postnatal astrocytes 
Figure 1. Characterization of MEA cultures. (a) MEA were incubated with a polyclonal anti-GFAP antibody, 
and GFAP immunoreactivity was detected using the avidin-biotin complex for amplifying the target antigen 
signal, as indicated in materials and methods. (b) Negative control (without anti-GFAP antibody). (c) MEA 
were incubated with a polyclonal anti-vimentin antibody. (d) MEF were incubated with the monoclonal anti-
GFAP antibody. In both cases, antigen signal was amplified as indicated above.
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expressing HRasV12 are also able to form detectable tumours within 8–15 weeks whereas tumours formed by 
Rb−/−/RasV12 appeared in-between the first and second week14.
Altogether, these different effects on cell growth and morphology suggest the existence of a different 
response to oncogenic stress between MEF and MEA. Therefore, to further investigate this possibility, we 
investigated the effect of oncogenic stress on cellular senescence in both cell types. As previously mentioned, 
OIS is part of the DDR and, in keeping with this, β-gal staining revealed a clear-cut increase in the number 
of senescent cells in MEF expressing oncogenic Ras. In contrast, the number of senescent cells was barely 
increased when oncogenic Ras was expressed in MEA (Fig. 3). Lack of Rb did not clearly modify the outcome 
of cells overexpressing HRasV12 in either MEF or MEA, although a slight decrease in the number of senescent 
cells was observed in both cases.
Finally, and to elucidate the mechanisms underlying this different response to OIS between MEA and MEF, 
we explored its effect of some of the well-characterized indicators of DDR in both cell types. As Fig. 4 depicts, 
Ras activation in MEF induced the accumulation of both p53 and p-p53Ser15, together with α-H2AX and p21CIP1. 
In all, these findings suggest the existence in these cells, as expected, of a DNA damage induced by Ras-driven 
DNA hypereplication. This effect was more evident in cells from Rb−/− mice, which probably reflects the fact that 
increased E2F activates p19ARF which, in turn, inhibits MDM2, thus favouring p53 accumulation. Interestingly, 
despite there is strong evidence indicating that activation of p53 is related to the induction of cell senescence, we 
were unable to find any correlation between the degree of activation of this pathway and the extent of cell senes-
cence. Thus, while senescence levels were slightly greater in cells from Rb+/+ mice than in their Rb−/− counter-
parts, the higher activation of p53 pathway was observed in Rb null cells.
However, the lack of correlation between biochemical and biological outcomes was more clearly evidenced in 
MEA. As previously stated, cellular senescence was barely present in these cells, even after activation of oncogenic 
Ras. Intriguingly, this lack of OIS was observed in cells that accumulate p53, p-p53Ser15, α-H2AX and p21CIP1, thus 
indicating the existence of a characteristic DDR response, similar to that observed in MEF. As occurred in MEF, 
the greatest activation of OIS checkpoints was observed in MEA obtained from Rb−/− HRasV12 mice, but also in 
this case, the correct activation of DDR was unable to induce cellular senescence.
Figure 2. Overexpression of HRasV12 induces cell cycle arrest in MEF but not in MEA. (a,b) Growth curve 
analysis of Rb+/+ or Rb−/− MEA (a) or MEF (b) infected with pBABE or pBABE-HRasV12 retroviral vectors. 
After infection, cells were plated in triplicate and the cells were fixed on the indicated days for subsequent 
staining with crystal violet. Each time point represents the mean ± S.D. of total cumulative cell number from at 
least three independent experiments. (c,d) Representative images of results presented in (a,b), respectively. All 
photographs are at the same magnification.
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Figure 3. Overexpression of HRasV12 induces senescence in MEF but not in MEA. (a,b) Senescence assays in 
Rb+/+ or Rb−/− MEA (a) or MEF (b) infected with pBABE or pBABE-HRasV12 retroviral vectors. The y-axis 
represents the percentage of SA-β-galactosidase-positive cells (mean ± S.D.) from at least three independent 
experiments. (c,d) Representative images of results presented in (a,b), respectively. All photographs are at the 
same magnification.
Figure 4. Uncoupling of the DDR from OIS in MEA but not in MEF. Immunoblot analysis of DNA damage 
checkpoint response performed on lysates prepared from Rb+/+ or Rb−/− MEA or MEF infected with pBABE or 
pBABE-HRasV12 retroviral vectors (5 and 4 days, respectively, after cell were seeded).
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Discussion
OIS is as a permanent state of proliferative arrest resulting from an activating oncogenic-lesion that has been sug-
gested to function as a cancer cell intrinsic mechanism to restrain tumour growth. However, albeit the role of OIS 
on the induction of proliferative arrest in response to an activating oncogenic event is broadly recognised5,6, there 
is also evidence indicating that cells may overcome OIS in some situations. In fact, in this report, we demonstrate 
that MEA are resistant to Ras-induced senescence despite adequate DDR activation, thus suggesting that OIS may 
be absent in these cells.
OIS was first evidenced as a senescence-like phenotype associated with overexpression of activated Ras pro-
teins12, but has been associated to ectopic expression of other oncogenes since that15–17. In mice, Ras-driven senes-
cence is mediated by activation of p19ARF which detects the oncogenic signal and triggers the phosphorylation 
of p53 tumour suppressor. Activation of p53 induces the expression of the cell cycle inhibitor p21, that causes 
growth arrest12,18. Consistent with this, overexpression of activated K-Ras does not trigger senescence in fibro-
blasts derived from p19ARF null mice19. In addition, DDR also induces expression of the CDK inhibitor p16INK4A, 
a tumour suppressor that blocks the inhibitory phosphorylation of RB20–22. Subsequent activation of RB silences 
the transcription of several E2F-dependent genes required for G1/S progression, thereby contributing to the 
arrest of cell proliferation23–25. However, p16INK4A null primary mouse fibroblasts remain susceptible to OIS26,27, 
thus suggesting that, at odds with p19ARF, this protein plays a minor role in promoting OIS, at least in those cells. 
In keeping with this, lack of RB barely modifies the outcome of OIS after Ras activation in either MEF or MEA.
Although this counter-intuitive concept that activation of oncogenes leads to growth arrest has become one of 
the mainstays of OIS, at least in mice, there is also evidence indicating that Ras-driven senescence can be bypassed 
under several conditions. Thus, in contrast with MEF response to the overexpression of oncogenic H-Ras, MEF 
expressing a single activated K-Ras allele are immortal9, and, similarly, inactivation of NF1 (which encodes a 
RasGAP protein) induces an activation of endogenous Ras that results in MEF immortalization10. Finally, H-Ras 
triggered senescence can be observed in mammary epithelial cells when high levels of activated Ras are present, 
while low levels of Ras may even trigger tumour formation if senescence checkpoints are inactivated12.
Although these findings support that signal intensity may play a key role in mediating a senescence response, 
there is also evidence indicating that other factors such as the cell type or even the species may be the actual 
matter. Thus, at odds with mice, p14ARF (the human homolog of p19ARF) does not show a so straightforward rela-
tionship with OIS, and although Ras-induced senescence has been reported, there is also evidence indicating that 
human fibroblasts may be resistant to Ras-driven senescence28. Similarly, HRasV12 has been also demonstrated to 
induce OIS independently of p53 in primary human oesophageal keratinocytes, while depletion of p53 allows the 
proliferation of HRasV12-expressing normal human fibroblasts5,29.
On this regard, we have found in the present study that, despite DDR is similar in MEA and MEF, senescence 
response is only observed in the latter. It must be taken in consideration that both MEA and MEF were obtained 
from the same animals and cultured under the same conditions, thus ruling out any influence of strain or genetic 
background, as well as other methodological pitfalls. To the present, MEF have been widely used to study many 
cellular processes such as cell growth, survival, differentiation or senescence, and have served as a helpful tool 
to recognize regulatory molecules involved in neoplastic transformation12,19,30–32. However, on the view of our 
results, we propose that some of the assumptions that have been originated from MEF, cannot be straightfor-
wardly extended to other cell types. Therefore, it is tempting to speculate that OIS mechanisms in MEF may 
reflect the low incidence of tumours in mesenchymal cells. On the contrary, ability of MEA to escape cellular 
senescence upon activation of Ras and elimination of RB could underlie the higher incidence of epithelial cancer. 
Further research will be needed in order to support the actual extent of this proposal.
In summary, the results presented in this study also support the view that Ras activation is not unavoidably 
linked to cell senescence even in mice, thus supporting the intriguingly possibility that OIS is not a widespread 
mechanism linking DDR and cellular senescence.
Methods
Primary monolayer cultures of either MEF or MEA were established from 13.5 dpc (day post coitum) Rb−/− or 
Rb+/+ mice. The care and use of all experimental animals was in accordance with institutional guidelines and 
approved by the Ethics Committee of the University of Santiago de Compostela and Xunta de Galicia (approval 
ID 15005AE/07/FUN01/FIS02/JACP1). Both cell types were plated in Falcon polystyrene culture dishes (BD 
Biosciences, Madrid, Spain) and grown in Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich, Madrid, 
Spain) supplemented with 10% foetal bovine serum (Thermo Fisher Scientific, Madrid, Spain), 2 mM glutamine, 
2.5 U/mL penicillin, 2.5 μg/mL and streptomycin (all from Thermo Fisher Scientific). The cultures were main-
tained at 37 °C in a humidified atmosphere of 5% CO2.
Pregnant mice were sacrificed at 13.5 dpc. Each embryo was transferred to individual petri dish with DMEM. 
Once red organs were dissected, the head and carcass of each embryo were individually transferred to new dry 
petri dishes for isolation and culture of MEA and MEF, respectively, and head was used to perform culture.
MEF cultures were performed as previously described33. Briefly, each chopped embryo carcass was resus-
pended in 5 mL of cold PBS and transferred into a 25 mL falcon tube and settled for 5 min. Supernatant was 
discarded and the process was repeated twice. PBS was replaced with 2 mL of cold trypsin/EDTA 0.05% (Thermo 
Fisher Scientific) and the cells were incubated at 4 °C for 6 to 18 hours, followed by incubation a 37 °C for 20 min. 
After 5 min of incubation, cells were dissociated by pipetting up and down thoroughly, and then trypsin was inac-
tivated by adding 2 volumes of complete medium.
Dissected heads were used for MEA culture as previously described, with appropriate modifications34. Each 
head was placed in a fresh petri dish with 1 mL of DMEM, and a transverse incision was performed in the fore-
head line. The brain was gently pushed out of the skull through the incision and, after removal of olfactory bulbs 
and cerebellum, was dissociated by mechanical shearing with a p1000 pipette in 1–2 mL of fresh medium. The cell 
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suspension was filtered through a 40 µm cell strainer (Millipore) with the help of the syringe plunger to obtain 
a total disaggregation of the cells. Then, the cell strainer was washed with 10 mL of DMEM and the cells were 
centrifuged for 5 min at 300 × g. Supernatant was carefully removed and the cells were resuspended in 10 mL 
of complete medium. To remove overlaying microglia and oligodendrocyte precursor cells34,35, cells underwent 
a harsh washing process entailing at least five rounds of intensive rinse with PBS followed by vigorous shaking 
of the culture dish. Cells were then cultured for 24 h and the washing process was repeated. Finally, cells were 
trypsinized and plated in the appropriate concentration.
Retroviral Transduction. For introduction of an activated Ras allele into MEA or MEF, cells were trans-
duced with pBABE-puro-empty or pBABE-puro-HRasV12 retroviral vectors (a gift from P.P. Pandolfi). Retrovirus 
Production and Infection were carried out using Phoenix-Eco packaging cells (a gift from G.P. Nolan) as previ-
ously described36. For each cell type (MEF or MEA), four experimental groups were established: control (Rb+/+), 
Rb−/−, Rb+/+-HRasV12 and Rb−/–HRasV12. Infection of MEF and MEA was carried out simultaneously using the 
same supernatant from transfected Phoenix cells. After retroviral infection MEF and MEA were selected with 
2 μg/mL of puromycin for 3 to 4 days before carrying out the experiments.
Proliferation assay. To measure proliferation, cells were seeded at low confluence in 24-well plates (1*105 
MEF or MEA per well) in triplicate and fixed in cold methanol for 15 min on indicated days for subsequent stain-
ing with crystal violet (0.05%) for 30 min. After washing, the cellular content of crystal violet was extracted with 
10% acetic acid, and the relative cell number was calculated based on the absorbance levels at 595 nm.
Immunocytochemistry. MEA were characterized in culture by immunocytochemistry using a monoclonal 
antibody against glial fibrillary acidic protein (GFAP; Agilent Technologies, Madrid, Spain; dilution 1:400) and a 
polyclonal anti-vimentin antibody (Abcam, Cambridge, MA; dilution 1:500). GFAP or vimentin immunoreactivi-
ties were detected using the EnVision Detection System (Agilent Technologies) according with the manufacturer’s 
instructions. MEF were used as negative controls.
SA-β-galactosidase assay. SA-β-galactosidase activity was assessed with the senescence β-galactosidase 
staining kit (Werfen, Barcelona, Spain) according with the manufacturer’s instructions.
Western blot. Cells were collected by centrifugation, washed twice in ice-cold PBS and lysed in ice-cold 
RIPA buffer (1x PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/mL PMSF, 40 mg of apro-
tinin/mL, 100 mM orthovanadate) (all reagents from Sigma-Aldrich). After centrifugation (15000 g, 15 min, 4 °C) 
to separate cellular debris, the lysates were resolved in a 12% SDS-PAGE, and electrotransferred onto a nitrocel-
lulose paper (Protran; Schleicher and Schuell, Dassel, Germany). Determination of protein levels was carried 
out by immunoblot analysis using antibodies against p53 (CM5; Leica Biosystems, Barcelona, Spain), p-p53Ser15 
(9284; Werfen), p-H2AX Ser139 (07–164, EMD Millipore, Madrid, Spain), p19ARF (ab80; Abcam), p16 (M-156; 
Santa Cruz Biotechnology, Heidelberg, Germany), pan-Ras-V12 (Ab-1; Sigma-Aldrich) and β-tubulin (T5168; 
Sigma-Aldrich).
Data Availability. No datasets were generated or analysed during the current study.
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